ScreenPro Security Inc. (SCRSF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 3.23 Million USD | -10.59% |
| 2022 | 2.76 Million USD | -0.91% |
| 2021 | 2.79 Million USD | 4816.17% |
| 2020 | 56.77 Thousand USD | 40.42% |
| 2019 | 40.43 Thousand USD | -47.41% |
| 2018 | 76.87 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 265.84 Thousand USD | -66.34% |
| 2024 Q2 | 136.65 Thousand USD | 21.82% |
| 2023 Q3 | 792.94 Thousand USD | 92.66% |
| 2023 Q2 | 411.58 Thousand USD | -4.55% |
| 2023 FY | 2.47 Million USD | -10.59% |
| 2023 Q1 | 431.19 Thousand USD | -34.37% |
| 2023 Q4 | 808.61 Thousand USD | 1.98% |
| 2022 Q4 | 656.97 Thousand USD | -23.54% |
| 2022 FY | 2.76 Million USD | -0.91% |
| 2022 Q3 | 859.22 Thousand USD | -36.53% |
| 2022 Q2 | 1.35 Million CAD | 56.98% |
| 2022 Q1 | 862.45 Thousand CAD | -76.96% |
| 2021 Q2 | 877.47 Thousand CAD | -41.58% |
| 2021 Q1 | 1.5 Million CAD | 4274.57% |
| 2021 Q3 | 725.92 Thousand CAD | -17.27% |
| 2021 FY | 2.79 Million USD | 4816.17% |
| 2021 Q4 | 3.74 Million USD | 415.55% |
| 2020 Q3 | 12 Thousand CAD | 0.0% |
| 2020 Q1 | 14 Thousand CAD | 3.58% |
| 2020 FY | 56.77 Thousand USD | 40.42% |
| 2020 Q4 | 34.33 Thousand CAD | 186.1% |
| 2020 Q2 | 12 Thousand CAD | -14.29% |
| 2019 Q4 | 13.51 Thousand CAD | 2.28% |
| 2019 FY | 40.43 Thousand USD | -47.41% |
| 2019 Q3 | 13.21 Thousand CAD | 10.47% |
| 2019 Q2 | 11.96 Thousand CAD | -12.9% |
| 2019 Q1 | 13.73 Thousand CAD | 0.0% |
| 2018 FY | 76.87 Thousand USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Bio Medica Corporation | 1.04 Million USD | -208.762% |
| Arrayit Corporation | 6.19 Million USD | 47.739% |
| Atlantic International Corp. | 5.57 Million USD | 41.937% |
| Biocept, Inc. | 29.4 Million USD | 88.984% |
| Bioqual, Inc. | 7.44 Million USD | 56.517% |
| CardioGenics Holdings Inc | 772.14 Thousand USD | -319.471% |
| DermTech, Inc. | 104.01 Million USD | 96.886% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 166.5 Million USD | 98.055% |
| HTG Molecular Diagnostics, Inc. | 22.62 Million USD | 85.684% |
| iMD Companies, Inc. | 151.8 Thousand USD | -2033.545% |
| IDenta Corp. | 662.97 Thousand USD | -388.542% |
| Interpace Biosciences, Inc. | 20.23 Million USD | 83.991% |
| Integrative Health Technologies, Inc. | 38.88 Thousand USD | -8230.323% |
| InVitro International | 661.32 Thousand USD | -389.762% |
| Lumos Diagnostics Holdings Limited | 7.09 Million USD | 54.369% |
| Many Bright Ideas Technologies Inc. | 58.11 Thousand USD | -5473.57% |
| Medical Imaging Corp. | 1.91 Million USD | -69.385% |
| NovelStem International Corp. | 3.53 Million USD | 8.448% |
| Optigenex Inc. | 1.28 Million USD | -151.494% |
| PharmChem, Inc. | 2.93 Million USD | -10.497% |
| Proteome Sciences plc | 3.26 Million USD | 0.89% |
| Response Genetics, Inc | 25.31 Million USD | 87.208% |
| Rennova Health, Inc. | 7.67 Million USD | 57.814% |
| RushNet, Inc. | 1.78 Million USD | -81.014% |
| Stella Diagnostics Inc. | 11.42 Million USD | 71.655% |
| StageZero Life Sciences Ltd. | 7.34 Million USD | 55.891% |
| Todos Medical Ltd. | 14.05 Million USD | 76.96% |